StockData
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) stock

MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.90−0.35 (-4.83%)

Close on Nov 16, 2026Market cap $320.01MP/E –Yield –

MapLight Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for MapLight Therapeutics

MapLight Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More MapLight Therapeutics figures

See a number that looks wrong?